Josep Oriola

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Refining risk stratification after indeterminate urinary cytology: Evidence from Bladder EpiCheck.

Refining risk stratification after indeterminate urinary cytology: Evidence from Bladder EpiCheck.

Journal: Cancer cytopathology

Published: March 29, 2026

Reclassification of an uncertain STK11 germline variant as likely pathogenic: a family study.

Reclassification of an uncertain STK11 germline variant as likely pathogenic: a family study.

Journal: Familial cancer

Published: April 10, 2025

Risk Factors for Pituitary Adenoma Development in Multiple Endocrine Neoplasia Type 1: A Nationwide Study of 240 Cases.

Risk Factors for Pituitary Adenoma Development in Multiple Endocrine Neoplasia Type 1: A Nationwide Study of 240 Cases.

Journal: The Journal of clinical endocrinology and metabolism

Published: February 19, 2025

Risk Factors Pituitary Adenomas Development in Multiple Endocrine Neoplasia Type 1: A Nationwide Study of 240 Cases.

Risk Factors Pituitary Adenomas Development in Multiple Endocrine Neoplasia Type 1: A Nationwide Study of 240 Cases.

Journal: The Journal of clinical endocrinology and metabolism

Published: February 19, 2025

Prevalence and clinical impact of germline pathogenic variants in breast cancer: a descriptive large single-center study.

Prevalence and clinical impact of germline pathogenic variants in breast cancer: a descriptive large single-center study.

Journal: ESMO open

Published: December 06, 2024

Should We Offer Universal Germline Genetic Testing to All Patients with Pancreatic Cancer? A Multicenter Study.

Should We Offer Universal Germline Genetic Testing to All Patients with Pancreatic Cancer? A Multicenter Study.

Journal: Cancers

Published: September 28, 2024

Considerations for hereditary breast and ovarian cancer syndrome molecular diagnosis: experience from the clinical practice.

Considerations for hereditary breast and ovarian cancer syndrome molecular diagnosis: experience from the clinical practice.

Journal: Breast cancer research and treatment

Published: August 14, 2024

Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency: clinical, biochemical and molecular characteristics and long-term outcomes.

Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency: clinical, biochemical and molecular characteristics and long-term outcomes.

Journal: Anales de pediatria

Published: July 02, 2024

Novel truncating germline variant reinforces TINF2 as a susceptibility gene for familial non-medullary thyroid cancer.

Novel truncating germline variant reinforces TINF2 as a susceptibility gene for familial non-medullary thyroid cancer.

Journal: Journal of medical genetics

Published: June 14, 2024

Long term outcomes of pituitary adenomas in Multiple Endocrine Neoplasia type 1: a nationwide study.

Long term outcomes of pituitary adenomas in Multiple Endocrine Neoplasia type 1: a nationwide study.

Journal: Frontiers in endocrinology

Published: May 04, 2024

Practical consensus for the treatment and follow-up of primary aldosteronism: a multidisciplinary consensus document.

Practical consensus for the treatment and follow-up of primary aldosteronism: a multidisciplinary consensus document.

Journal: Endocrine

Published: February 06, 2024

Screening and diagnosis of primary aldosteronism. Consensus document of all the Spanish Societies involved in the management of primary aldosteronism.

Screening and diagnosis of primary aldosteronism. Consensus document of all the Spanish Societies involved in the management of primary aldosteronism.

Journal: Endocrine

Published: January 25, 2024

Showing 1-12 of 43

Last Updated: 09/26/2026